Is Group B strep (Streptococcus agalactiae) a gram-positive aerobe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Group B Streptococcus (Streptococcus agalactiae) Classification

Yes, Group B Streptococcus (Streptococcus agalactiae) is a gram-positive bacterium that is facultatively anaerobic, meaning it can grow in both aerobic and anaerobic conditions. 1, 2

Microbiological Characteristics

  • Group B Streptococcus (GBS) is definitively classified as a gram-positive coccus that can survive and grow in both oxygen-rich and oxygen-poor environments (facultative anaerobe) 1, 2
  • GBS is beta-hemolytic, producing a clear zone of hemolysis when grown on blood agar plates 2
  • It is encapsulated with a polysaccharide capsule, which serves as a major virulence factor, with 10 known serotypes based on immunological activity 2
  • GBS differs from Group A Streptococcus, which is more commonly associated with pharyngitis and skin infections 3

Clinical Significance

  • GBS is the leading infectious cause of morbidity and mortality among infants in the United States 1
  • It colonizes the lower genital tract of approximately 18% of women globally as an asymptomatic member of the gastrointestinal and/or vaginal flora 4
  • The gastrointestinal tract is considered the most likely human reservoir of GBS, with the genitourinary tract being the most common site of secondary spread 1
  • In pregnant women, colonization rates range from 10% to 30% in the vaginal or rectal areas 1

Laboratory Identification

  • Culture of GBS on sheep blood agar is the standard method for identification 1
  • The CDC drug label confirms that Streptococcus agalactiae is among the gram-positive aerobes susceptible to certain antibiotics like cefazolin 5
  • For optimal detection, specimens should be collected from both the anorectum and vaginal introitus, which increases the likelihood of GBS isolation by 5%-27% over vaginal culture alone 1
  • The evidence for the benefit of anaerobic incubation in GBS culture is not clearly established according to CDC guidelines 3

Disease Prevention

  • Screening pregnant women at 35-37 weeks gestation with both rectal and vaginal swabs is recommended to identify carriers 3
  • Intrapartum antibiotic prophylaxis is the primary strategy for preventing early-onset GBS disease in newborns 1
  • The incidence of early-onset GBS disease has declined dramatically from 1.7 cases per 1,000 live births in the early 1990s to 0.34-0.37 cases per 1,000 live births in recent years due to prevention efforts 1

Transmission and Colonization

  • GBS colonization is dynamic, with a 3-week incidence of 11.3% among women and 8.8% among men in a dormitory setting 6
  • The estimated average duration of GBS colonization is longer for women (13.7 weeks) than men (8.5 weeks) 6
  • Colonization with more than one serotype occurs significantly less than would be expected by chance 6
  • GBS is not transmitted by casual contact, as transmission between roommate pairs occurs at the expected rate based on overall incidence 6

Understanding the gram-positive, facultatively anaerobic nature of GBS is essential for proper laboratory identification, clinical management, and prevention strategies for GBS-related diseases.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.